9997.HK Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 апр. 2024 @ 11:08):

Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China...

Stats
Объем за сегодня	1.11M
Средний объем	752 134
Рыночная капитализация	8.59B
EPS	HKD0 ( 2024-03-24 )
Дата следующего отчета о доходах	( HKD0 ) 2024-05-27
Last Dividend	HKD0.205 ( 2023-05-30 )
Next Dividend	HKD0 ( N/A )
P/E	15.74
ATR14	HKD0.00600 (0.08%)

Объем Корреляция

Длинно: 0.19 (neutral)

Кратко: -0.67 (moderate negative)

Signal:(39.168) Neutral

Kangji Medical Holdings Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Kangji Medical Holdings Корреляция - Валюта/Сырье

0.57
( weak )

0.79
( moderate )

0.00
( neutral )

-0.34
( neutral )

0.12
( neutral )

-0.81
( strong negative )

Kangji Medical Holdings Финансовые показатели

Annual	2023
Выручка:	HKD926.02M
Валовая прибыль:	HKD741.20M (80.04 %)
EPS:	HKD0.430

FY	2023
Выручка:	HKD926.02M
Валовая прибыль:	HKD741.20M (80.04 %)
EPS:	HKD0.430

FY	2022
Выручка:	HKD786.37M
Валовая прибыль:	HKD635.25M (80.78 %)
EPS:	HKD0.400

FY	2021
Выручка:	HKD690.26M
Валовая прибыль:	HKD562.93M (81.55 %)
EPS:	HKD0.373

Financial Reports:

No articles found.

Kangji Medical Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.205 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Kangji Medical Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.32 - Stable (6.48%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0440	2021-05-28
Last Dividend	HKD0.205	2023-05-30
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.421	--
Avg. Dividend % Per Year	0.00%	--
Score	3.1	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.32
Div. Directional Score	8.55	--

Next Divdend (Est)
(2025-03-31)

HKD0.237 Estimate 3.06 %

Dividend Stability

0.24 Very Poor

Dividend Score

3.10

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
3311.HK	Ex Dividend Junior	2023-06-19	Semi-Annually	0.00%
1523.HK	Ex Dividend Knight	2023-08-09	Semi-Annually	0.00%
0573.HK	Ex Dividend Knight	2023-10-05	Annually	0.00%
8476.HK	Ex Dividend Knight	2023-08-22	Annually	0.00%
2039.HK	Ex Dividend Junior	2023-07-25	Annually	0.00%
1109.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
0175.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
3788.HK	Ex Dividend Knight	2023-10-05	Annually	0.00%
1681.HK	Ex Dividend Knight	2023-06-08	Semi-Annually	0.00%
0716.HK	Ex Dividend Junior	2023-09-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.544	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.118	1.200	6.06	7.27	[0 - 0.3]
returnOnEquityTTM	0.138	1.500	9.58	10.00	[0.1 - 1]
payoutRatioTTM	0.429	-1.000	5.71	-5.71	[0 - 1]
currentRatioTTM	17.72	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	15.27	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	14.03	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.00888	-1.500	9.85	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.359	2.00	9.88	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.284	2.00	9.86	10.00	[0 - 20]
debtEquityRatioTTM	0.0104	-1.500	9.96	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.800	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.478	1.000	2.44	2.44	[0.1 - 0.6]
cashFlowToDebtRatioTTM	11.08	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	0.217	0.800	-1.885	-1.508	[0.5 - 2]
Total Score				11.78

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.77	1.000	8.51	0	[1 - 100]
returnOnEquityTTM	0.138	2.50	9.73	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.284	2.00	9.91	10.00	[0 - 30]
dividendYielPercentageTTM	3.02	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.359	2.00	9.88	10.00	[0 - 30]
payoutRatioTTM	0.429	1.500	5.71	-5.71	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.453	1.000	1.172	0	[0.1 - 0.5]
Total Score				5.32

Kangji Medical Holdings

Kangji Medical Holdings Limited, through its subsidiaries, designs, develops, manufactures, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, ultrasonic scalpels, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.